StonvexLoading…
StonvexStonvexStonvexCore line items from JAZZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.07B | $4.27B | $3.07B | $1.94B |
Operating Income | $336.60M | $-430.24M | $-684.77M | $-742.28M |
Net Income | $293.10M | $-356.15M | $-559.60M | $-718.47M |
EPS (Diluted) | $4.43 | $-5.84 | $-9.18 | $-13.28 |
Total Assets | $11.86B | $11.66B | $11.36B | $10.94B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.84B | $1.39B | $1.33B | $1.19B |
Free Cash Flow OCF − CapEx | $388.50M | $1.30B | $951.23M | $491.79M |
Shares Outstanding | 66.10M | 61.44M | 60.95M | 61.09M |